Table 1—

Conventional echocardiography measurements in patients with systemic sclerosis and control subjects

ControlsSystemic sclerosisp-value
Subjects n1325
Aortic cardiac output L·min−1·m-22.9±0.43±0.70.68
Tricuspid regurgitant jet maximal velocity m·s−12.2±0.32.4±0.40.2
Systolic RV pressure gradient mmHg20±523±80.2
Pulmonary acceleration time ms141±17123±240.02
Pulmonary acceleration time/ejection time %45±640±70.03
RV end-diastolic free wall thickness mm3.7±6.55.6±2.00.01
RV end-diastolic area cm29.4±2.611.1±2.70.06
RV/LV end-diastolic area ratio %32.8±6.239.9±9.20.02
RV area shortening fraction %59.8±9.954.8±8.50.1
RV performance index0.19±0.050.27±0.150.07
TAPSE cm2.7±0.32.4±0.50.1
Tricuspid flow E cm·s−156±1244±110.007
Tricuspid flow A cm·s−132±1136±110.4
Tricuspid flow E/A1.9±0.61.3±0.40.008
LV ejection fraction %71.6±7.970.5±9.10.7
Mitral flow E cm·s−184±1980±230.6
Mitral flow A cm·s−170±1671±280.9
Mitral flow E/A1.3±0.41.3±0.50.9
  • Data are presented as mean±sd, unless otherwise stated. RV: right ventricle; LV: left ventricle; TAPSE: tricuspid annular plane systolic excursion; E: early diastolic wave; A: late diastolic wave.